OptimizeRx (OPRX) Competitors

Upbound Group (NASDAQ:UPBD) and OptimizeRx (NASDAQ:OPRX) are both small-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

Which has higher valuation and earnings, UPBD or OPRX?

Upbound Group has higher revenue and earnings than OptimizeRx. OptimizeRx is trading at a lower price-to-earnings ratio than Upbound Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Upbound Group	$4.32B	0.34	$123.48M	$1.78	14.16
OptimizeRx	$104.75M	3.04	-$18.66M	-$0.54	-31.80

Do analysts recommend UPBD or OPRX?

Upbound Group presently has a consensus price target of $34.50, suggesting a potential upside of 36.85%. OptimizeRx has a consensus price target of $11.81, suggesting a potential downside of 31.20%. Given Upbound Group's stronger consensus rating and higher probable upside, equities analysts plainly believe Upbound Group is more favorable than OptimizeRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Upbound Group	0 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.80
OptimizeRx	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73

Do insiders and institutionals hold more shares of UPBD or OPRX?

90.3% of Upbound Group shares are owned by institutional investors. Comparatively, 76.5% of OptimizeRx shares are owned by institutional investors. 2.6% of Upbound Group shares are owned by insiders. Comparatively, 5.6% of OptimizeRx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Which has more volatility and risk, UPBD or OPRX?

Upbound Group has a beta of 1.74, indicating that its stock price is 74% more volatile than the S&P 500. Comparatively, OptimizeRx has a beta of 1.33, indicating that its stock price is 33% more volatile than the S&P 500.

Does the media prefer UPBD or OPRX?

In the previous week, OptimizeRx had 1 more articles in the media than Upbound Group. MarketBeat recorded 6 mentions for OptimizeRx and 5 mentions for Upbound Group. Upbound Group's average media sentiment score of 1.63 beat OptimizeRx's score of 0.67 indicating that Upbound Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Upbound Group	5 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
OptimizeRx	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is UPBD or OPRX more profitable?

Upbound Group has a net margin of 2.28% compared to OptimizeRx's net margin of -9.42%. Upbound Group's return on equity of 36.26% beat OptimizeRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Upbound Group	2.28%	36.26%	8.31%
OptimizeRx	-9.42%	4.50%	3.12%

Summary

Upbound Group beats OptimizeRx on 13 of the 17 factors compared between the two stocks.